SCHEMBL1031173

SCHEMBL1031173

COc1ccc(F)cc1-c1ccnc(NC2CCCCC2)n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGER Q15109 1/20 0.54
CDK1 P06493 6/20 0.53
CCNB1 P14635 6/20 0.53
CDK4 P11802 4/20 0.53
CCNA2 P20248 3/20 0.53
CCND1 P24385 3/20 0.53
CDK2 P24941 3/20 0.53
CCNA1 P78396 3/20 0.53
CCNT1 O60563 2/20 0.50
CDK9 P50750 2/20 0.50
CCNE1 P24864 1/20 0.50
CCND3 P30281 1/20 0.50
CDK6 Q00534 1/20 0.50
CCNB2 O95067 3/20 0.49
CCNB3 Q8WWL7 3/20 0.49
KCNH2 Q12809 2/20 0.48
GSK3B P49841 2/20 0.48
CDC7 O00311 1/20 0.48
PLK4 O00444 1/20 0.48
JAK2 O60674 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1031594 0.87 EIF2AK2 (0.59) AGERCDK1CCNB1CDK4CCNA2
SCHEMBL1032136 0.86 SMN1; SMN2 (0.62) AGERCDK1CCNB1CDK4CCNA2
SCHEMBL3620677 0.86 SMN1; SMN2 (0.62) AGERCDK1CCNB1CDK4CCNA2
SCHEMBL1033029 0.85 AGER (0.55) AGERCDK1CCNB1CDK4CCNA2
SCHEMBL1034516 0.85 SMN1; SMN2 (0.60) AGERCDK1CCNB1CDK4CCNA2
SCHEMBL1033580 0.84 CDK1 (0.55) CDK1CCNB1CDK4CCNA2CCND1
SCHEMBL1032673 0.82 CDK1 (0.55) CDK1CCNB1CDK4CCNA2CCND1
SCHEMBL1029097 0.80 ALDH1A1 (0.55) AGERCDK1CCNB1CDK4CCNA2
SCHEMBL1033717 0.77 SMN1; SMN2 (0.48) CDK1CCNB1CDK4CCNA2CCND1
SCHEMBL1034820 0.76 CDK4 (0.57) CDK1CCNB1CDK4CCNA2CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO claimed
WO-2011008931-A2 ARYLPYRIMIDINE COMPOUNDS AND COMBINATION THERAPY COMPRISING SAME FOR TREATING CYSTIC FIBROSIS & RELATED DISORDERS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2011-01-20 WO disclosed
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO disclosed